Cargando…
REV7 is required for processing AID initiated DNA lesions in activated B cells
Activation-induced cytidine deaminase (AID) initiates both antibody class switch recombination (CSR) and somatic hypermutation (SHM) in antibody diversification. DNA double-strand break response (DSBR) factors promote rearrangement in CSR, while translesion synthesis (TLS) polymerases generate mutat...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272641/ https://www.ncbi.nlm.nih.gov/pubmed/32499490 http://dx.doi.org/10.1038/s41467-020-16632-8 |
_version_ | 1783542297695092736 |
---|---|
author | Yang, Dingpeng Sun, Ying Chen, Jingjing Zhang, Ying Fan, Shuangshuang Huang, Min Xie, Xia Cai, Yanni Shang, Yafang Gui, Tuantuan Sun, Liming Hu, Jiazhi Dong, Junchao Yeap, Leng-Siew Wang, Xiaoming Xiao, Wei Meng, Fei-Long |
author_facet | Yang, Dingpeng Sun, Ying Chen, Jingjing Zhang, Ying Fan, Shuangshuang Huang, Min Xie, Xia Cai, Yanni Shang, Yafang Gui, Tuantuan Sun, Liming Hu, Jiazhi Dong, Junchao Yeap, Leng-Siew Wang, Xiaoming Xiao, Wei Meng, Fei-Long |
author_sort | Yang, Dingpeng |
collection | PubMed |
description | Activation-induced cytidine deaminase (AID) initiates both antibody class switch recombination (CSR) and somatic hypermutation (SHM) in antibody diversification. DNA double-strand break response (DSBR) factors promote rearrangement in CSR, while translesion synthesis (TLS) polymerases generate mutations in SHM. REV7, a component of TLS polymerase zeta, is also a downstream effector of 53BP1-RIF1 DSBR pathway. Here, we study the multi-functions of REV7 and find that REV7 is required for the B cell survival upon AID-deamination, which is independent of its roles in DSBR, G2/M transition or REV1-mediated TLS. The cell death in REV7-deficient activated B cells can be fully rescued by AID-deficiency in vivo. We further identify that REV7-depedent TLS across UNG-processed apurinic/apyrimidinic sites is required for cell survival upon AID/APOBEC deamination. This study dissects the multiple roles of Rev7 in antibody diversification, and discovers that TLS is not only required for sequence diversification but also B cell survival upon AID-initiated lesions. |
format | Online Article Text |
id | pubmed-7272641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-72726412020-06-15 REV7 is required for processing AID initiated DNA lesions in activated B cells Yang, Dingpeng Sun, Ying Chen, Jingjing Zhang, Ying Fan, Shuangshuang Huang, Min Xie, Xia Cai, Yanni Shang, Yafang Gui, Tuantuan Sun, Liming Hu, Jiazhi Dong, Junchao Yeap, Leng-Siew Wang, Xiaoming Xiao, Wei Meng, Fei-Long Nat Commun Article Activation-induced cytidine deaminase (AID) initiates both antibody class switch recombination (CSR) and somatic hypermutation (SHM) in antibody diversification. DNA double-strand break response (DSBR) factors promote rearrangement in CSR, while translesion synthesis (TLS) polymerases generate mutations in SHM. REV7, a component of TLS polymerase zeta, is also a downstream effector of 53BP1-RIF1 DSBR pathway. Here, we study the multi-functions of REV7 and find that REV7 is required for the B cell survival upon AID-deamination, which is independent of its roles in DSBR, G2/M transition or REV1-mediated TLS. The cell death in REV7-deficient activated B cells can be fully rescued by AID-deficiency in vivo. We further identify that REV7-depedent TLS across UNG-processed apurinic/apyrimidinic sites is required for cell survival upon AID/APOBEC deamination. This study dissects the multiple roles of Rev7 in antibody diversification, and discovers that TLS is not only required for sequence diversification but also B cell survival upon AID-initiated lesions. Nature Publishing Group UK 2020-06-04 /pmc/articles/PMC7272641/ /pubmed/32499490 http://dx.doi.org/10.1038/s41467-020-16632-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Yang, Dingpeng Sun, Ying Chen, Jingjing Zhang, Ying Fan, Shuangshuang Huang, Min Xie, Xia Cai, Yanni Shang, Yafang Gui, Tuantuan Sun, Liming Hu, Jiazhi Dong, Junchao Yeap, Leng-Siew Wang, Xiaoming Xiao, Wei Meng, Fei-Long REV7 is required for processing AID initiated DNA lesions in activated B cells |
title | REV7 is required for processing AID initiated DNA lesions in activated B cells |
title_full | REV7 is required for processing AID initiated DNA lesions in activated B cells |
title_fullStr | REV7 is required for processing AID initiated DNA lesions in activated B cells |
title_full_unstemmed | REV7 is required for processing AID initiated DNA lesions in activated B cells |
title_short | REV7 is required for processing AID initiated DNA lesions in activated B cells |
title_sort | rev7 is required for processing aid initiated dna lesions in activated b cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272641/ https://www.ncbi.nlm.nih.gov/pubmed/32499490 http://dx.doi.org/10.1038/s41467-020-16632-8 |
work_keys_str_mv | AT yangdingpeng rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT sunying rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT chenjingjing rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT zhangying rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT fanshuangshuang rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT huangmin rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT xiexia rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT caiyanni rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT shangyafang rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT guituantuan rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT sunliming rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT hujiazhi rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT dongjunchao rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT yeaplengsiew rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT wangxiaoming rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT xiaowei rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells AT mengfeilong rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells |